- Home
- RBNE vs TNON Comparison
RBNE vs TNON Comparison
Compare RBNE & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RBNE | TNON |
|---|---|---|
| Founded | 2024 | 2012 |
| Country | Cyprus | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8M | 12.8M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | RBNE | TNON |
|---|---|---|
| Price | $2.97 | $0.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 184.1K | 84.7K |
| Earning Date | 02-21-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,233,000.00 |
| Revenue This Year | N/A | $19.56 |
| Revenue Next Year | N/A | $71.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.78 | $0.85 |
| 52 Week High | $123.25 | $5.85 |
Technical Indicators
Market Signals| Indicator | RBNE | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 81.37 | 34.11 |
| Support Level | $2.78 | $0.93 |
| Resistance Level | $3.50 | $1.13 |
| Average True Range (ATR) | 0.22 | 0.05 |
| MACD | 0.24 | -0.01 |
| Stochastic Oscillator | 75.21 | 13.38 |
Price Performance
Historical ComparisonAbout RBNE Robin Energy Ltd.
Robin Energy Ltd operates a tanker vessel that engages in the transportation of refined petroleum products using its Handysize product tanker.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.